StockData
ResMed Inc logo

ResMed Inc (RMD) stock

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3014% below fair value
$237.85−0.34 (-0.14%)

Close on Nov 17, 2026Market cap $33.46BP/E 21.7Yield 1.01%

ResMed cash

Cash and short-term investments held at the end of each period.

ResMed's cash was $1.01B at Sep 30, 2026. For fiscal 2026 it was $1.47B, up 21.5% from the year before. Over ten years it grew 7.2% a year on average. The highest annual figure on record is $1.47B in fiscal 2026.

Annual cash

PeriodPeriod endValueChange
FY2026Jun 30, 2026$1.47B+21.5%
FY2025Jun 30, 2025$1.21B+407.4%
FY2024Jun 30, 2024$238.36M+4.6%
FY2023Jun 30, 2023$227.89M-16.7%
FY2022Jun 30, 2022$273.71M-7.3%
FY2021Jun 30, 2021$295.28M-36.2%
FY2020Jun 30, 2020$463.16M+214.8%
FY2019Jun 30, 2019$147.13M-22.0%
FY2018Jun 30, 2018$188.70M-77.0%
FY2017Jun 30, 2017$821.94M+12.4%
FY2016Jun 30, 2016$731.43M+2.0%
FY2015Jun 30, 2015$717.25M-20.8%
FY2014Jun 30, 2014$905.73M+3.4%
FY2013Jun 30, 2013$876.05M+8.2%
FY2012Jun 30, 2012$809.54M+10.1%
FY2011Jun 30, 2011$735.27M+50.4%
FY2010Jun 30, 2010$488.78M+17.6%
FY2009Jun 30, 2009$415.65M+29.5%
FY2008Jun 30, 2008$321.08M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$1.01B-27.0%
Q4 FY2026CQ2 2026Jun 30, 2026$1.47B+21.5%
Q3 FY2026CQ1 2026Mar 31, 2026$1.66B+78.0%
Q2 FY2026CQ4 2025Dec 31, 2025$1.42B+171.5%
Q1 FY2026CQ3 2025Sep 30, 2025$1.38B+224.6%
Q4 FY2025CQ2 2025Jun 30, 2025$1.21B+407.4%
Q3 FY2025CQ1 2025Mar 31, 2025$932.71M+292.0%
Q2 FY2025CQ4 2024Dec 31, 2024$521.94M+148.3%
Q1 FY2025CQ3 2024Sep 30, 2024$426.36M+103.9%
Q4 FY2024CQ2 2024Jun 30, 2024$238.36M+4.6%
Q3 FY2024CQ1 2024Mar 31, 2024$237.91M+4.4%
Q2 FY2024CQ4 2023Dec 31, 2023$210.25M-17.0%
Q1 FY2024CQ3 2023Sep 30, 2023$209.10M+0.9%
Q4 FY2023CQ2 2023Jun 30, 2023$227.89M-16.7%
Q3 FY2023CQ1 2023Mar 31, 2023$227.89M+12.9%
Q2 FY2023CQ4 2022Dec 31, 2022$253.20M+30.2%
Q1 FY2023CQ3 2022Sep 30, 2022$207.16M-25.0%
Q4 FY2022CQ2 2022Jun 30, 2022$273.71M-7.3%
Q3 FY2022CQ1 2022Mar 31, 2022$201.77M-12.5%
Q2 FY2022CQ4 2021Dec 31, 2021$194.48M-24.0%
Q1 FY2022CQ3 2021Sep 30, 2021$276.15M-34.5%
Q4 FY2021CQ2 2021Jun 30, 2021$295.28M-36.2%
Q3 FY2021CQ1 2021Mar 31, 2021$230.64M-34.6%
Q2 FY2021CQ4 2020Dec 31, 2020$255.87M+25.4%
Q1 FY2021CQ3 2020Sep 30, 2020$421.41M+144.8%
Q4 FY2020CQ2 2020Jun 30, 2020$463.16M+214.8%
Q3 FY2020CQ1 2020Mar 31, 2020$352.86M+140.8%
Q2 FY2020CQ4 2019Dec 31, 2019$204.10M+36.5%
Q1 FY2020CQ3 2019Sep 30, 2019$172.15M-25.2%
Q4 FY2019CQ2 2019Jun 30, 2019$147.13M-22.0%
Q3 FY2019CQ1 2019Mar 31, 2019$146.51M-79.2%
Q2 FY2019CQ4 2018Dec 31, 2018$149.47M-82.6%
Q1 FY2019CQ3 2018Sep 30, 2018$230.19M-71.6%
Q4 FY2018CQ2 2018Jun 30, 2018$188.70M-77.0%
Q3 FY2018CQ1 2018Mar 31, 2018$704.28M-14.9%
Q2 FY2018CQ4 2017Dec 31, 2017$858.90M+9.0%
Q1 FY2018CQ3 2017Sep 30, 2017$811.10M–
Q4 FY2017CQ2 2017Jun 30, 2017$821.94M–
Q3 FY2017CQ1 2017Mar 31, 2017$827.31M–
Q2 FY2017CQ4 2016Dec 31, 2016$788.15M–

More ResMed figures

See a number that looks wrong?